Number | Contraindications |
---|---|
1. | Unknown cause of death or significant disease of unknown etiology in the medical history |
2. | Viral donor diseases: Infection with HIV, hepatitis B/C, HTLV I/II |
3. | Bacterial donor diseases: Syphilis or other chronic persistent bacterial infections (brucellosis, typhus, rickettsioses, leprosy, relapsing fever, tularemia) |
4. | Protozoonotic donor diseases: Babesiosis, trypanosomiasis (e.g., Chagas disease), Leishmaniasis |
5. | Active systemic infections: bacterial, viral, fungal, parasitic or of unclear etiology |
6. | Fungal sepsis or sepsis with multi-resistant germs (a bacterial sepsis with usual spectrum is not a contraindication) |
7. | Central nervous disorders of unknown cause: (M. Alzheimer, M. Parkinson, unclear fast progressive Dementia, Multiple Sclerosis, Amyotrophic Lateral Sclerosis) |
8. | Hematological neoplasias, leukemias, lymphomas |
9. | Ophthalmic donor diseases with visible change in the cornea (corneal surgery, local infections, tumors of the eye) |
10. | Risk of disease transmission by prions: recipients of dura mater, cornea, sclera, hetero- or xenografts; recipients of pituitary hormones |
11. | Premortal uptake of substances that by transplanting can lead to a harmful effect (poisons, heavy metals) |
12. | Donors who had premortal blood transfusion in the last 48 h with a limit of 22.5 ml per kg of body weight |
13. | Time-limited exclusion: 2 years after healing: Salmonellosis, Q fever; Tuberculosis, Leptospirosis; 4 years after the cure of Malaria; 4 weeks after healing of Measles, Rubella, VZV |
14. | Risk for ZIKA virus infection: (clinical signs of infection or stay within the last 28 days before death in a Zika virus endemic area (Uganda, Africa, Asia Micronesia, French Polynesia, Brazil, Columbia, Venezuela, Central America)) |
15. | Infections with MRSA / ESBL / VRSA |